Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3,5-diarylazaindoles as DYRK1A protein inhibitors for the treatment of cognitive deficiencies associated with Down's syndrome and with Alzheimer's disease

3,5-diarylazaindoles as DYRK1A protein inhibitors for the treatment of cognitive deficiencies associated with Down's syndrome and with Alzheimer's disease

US Patent 9447093 · Granted Sep 20, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2- or 3-imidazolines as carbapenemases inhibitors2022
Azetidinimines as carbapenemases inhibitors2021
Metalloprotease inhibitors, methods for producing same, and therapeutics uses th2017